Holdings of the Fund as of 3/31/2025
Total Number of Holdings (excluding cash): 49
Penumbra, Inc. |
PEN |
70975L107 |
221 |
$59,097.61 |
2.93% |
WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
6,185 |
$55,233.87 |
2.74% |
Masimo Corporation |
MASI |
574795100 |
319 |
$53,145.40 |
2.64% |
Boston Scientific Corporation |
BSX |
101137107 |
515 |
$51,953.20 |
2.58% |
Abbott Laboratories |
ABT |
002824100 |
386 |
$51,202.90 |
2.54% |
Insulet Corporation |
PODD |
45784P101 |
193 |
$50,683.73 |
2.52% |
Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
433 |
$49,006.94 |
2.43% |
Edwards Lifesciences Corporation |
EW |
28176E108 |
658 |
$47,691.84 |
2.37% |
Stryker Corporation |
SYK |
863667101 |
126 |
$46,903.50 |
2.33% |
BioMerieux |
BIM.FP |
F1149Y232 |
376 |
$46,476.84 |
2.31% |
Globus Medical, Inc. (Class A) |
GMED |
379577208 |
635 |
$46,482.00 |
2.31% |
Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$46,060.11 |
2.29% |
Waters Corporation |
WAT |
941848103 |
125 |
$46,071.25 |
2.29% |
Medtronic Plc |
MDT |
G5960L103 |
502 |
$45,109.72 |
2.24% |
Steris Plc |
STE |
G8473T100 |
197 |
$44,650.05 |
2.22% |
Sysmex Corporation |
6869.JP |
J7864H102 |
2,334 |
$44,555.36 |
2.21% |
DexCom, Inc. |
DXCM |
252131107 |
648 |
$44,251.92 |
2.20% |
Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,156 |
$44,381.58 |
2.20% |
Alcon Inc. |
ALC.SW |
H01301128 |
464 |
$44,026.66 |
2.18% |
Becton, Dickinson and Company |
BDX |
075887109 |
189 |
$43,292.34 |
2.15% |
Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
218 |
$43,189.65 |
2.14% |
Terumo Corporation |
4543.JP |
J83173104 |
2,260 |
$42,523.53 |
2.11% |
Baxter International Inc. |
BAX |
071813109 |
1,227 |
$42,000.21 |
2.08% |
ResMed Inc. |
RMD |
761152107 |
187 |
$41,859.95 |
2.08% |
Siemens Healthineers AG |
SHL.GY |
D6T479107 |
777 |
$41,919.54 |
2.08% |
Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
617 |
$40,784.53 |
2.02% |
GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
493 |
$39,790.03 |
1.97% |
Revvity, Inc. |
RVTY |
714046109 |
369 |
$39,040.20 |
1.94% |
Demant A/S |
DEMANT.DC |
K3008M105 |
1,157 |
$38,882.23 |
1.93% |
Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,977 |
$37,729.85 |
1.87% |
Cochlear Limited |
COH.AU |
Q25953102 |
227 |
$37,411.77 |
1.86% |
Thermo Fisher Scientific Inc. |
TMO |
883556102 |
75 |
$37,320.00 |
1.85% |
Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$36,608.21 |
1.82% |
Agilent Technologies, Inc. |
A |
00846U101 |
312 |
$36,497.76 |
1.81% |
Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
347 |
$36,394.67 |
1.81% |
Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
294 |
$35,592.82 |
1.77% |
Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,395 |
$35,514.18 |
1.76% |
The Cooper Companies, Inc. |
COO |
216648501 |
420 |
$35,427.00 |
1.76% |
Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
121 |
$35,329.66 |
1.75% |
Hologic, Inc. |
HOLX |
436440101 |
562 |
$34,714.74 |
1.72% |
Danaher Corporation |
DHR |
235851102 |
166 |
$34,030.00 |
1.69% |
West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$34,029.76 |
1.69% |
Hoya Corporation |
7741.JP |
J22848105 |
294 |
$33,179.84 |
1.65% |
Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
133 |
$32,393.48 |
1.61% |
Align Technology, Inc. |
ALGN |
016255101 |
202 |
$32,089.72 |
1.59% |
Olympus Corporation |
7733.JP |
J61240107 |
2,340 |
$30,631.80 |
1.52% |
Amplifon SpA |
AMP.IM |
T0388E118 |
1,495 |
$30,350.14 |
1.51% |
Exact Sciences Corporation |
EXAS |
30063P105 |
632 |
$27,359.28 |
1.36% |
Teleflex Incorporated |
TFX |
879369106 |
190 |
$26,256.10 |
1.30% |
US Dollar |
$USD |
|
5,582 |
$5,582.44 |
0.28% |
Australian Dollar |
$AUD |
|
459 |
$286.64 |
0.01% |
Euro |
$EUR |
|
0 |
$0.05 |
0.00% |
Pound Sterling |
$GBP |
|
0 |
$0.14 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|